127 related articles for article (PubMed ID: 31756160)
41. Intact Mass Quantitation of Therapeutic Antibodies for Pharmacokinetic Studies Using Immuno-Purification.
Vasicek LA; Spellman DS; Bateman KP
Methods Mol Biol; 2022; 2313():259-268. PubMed ID: 34478143
[TBL] [Abstract][Full Text] [Related]
42. Mass spectrometry for structural characterization of therapeutic antibodies.
Zhang Z; Pan H; Chen X
Mass Spectrom Rev; 2009; 28(1):147-76. PubMed ID: 18720354
[TBL] [Abstract][Full Text] [Related]
43. Subunit mass analysis for monitoring multiple attributes of monoclonal antibodies.
Liu P; Zhu X; Wu W; Ludwig R; Song H; Li R; Zhou J; Tao L; Leone AM
Rapid Commun Mass Spectrom; 2019 Jan; 33(1):31-40. PubMed ID: 30286260
[TBL] [Abstract][Full Text] [Related]
44. Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysis.
Shi RL; Xiao G; Dillon TM; Ricci MS; Bondarenko PV
MAbs; 2020; 12(1):1739825. PubMed ID: 32292112
[TBL] [Abstract][Full Text] [Related]
45. Quantitation of Insulin-Like Growth Factor 1 in Serum by Liquid Chromatography High Resolution Accurate-Mass Mass Spectrometry.
Ketha H; Singh RJ
Methods Mol Biol; 2016; 1378():131-7. PubMed ID: 26602125
[TBL] [Abstract][Full Text] [Related]
46. Application of middle-down approach in quantitation and catabolite identification of protein by LC-high-resolution mass spectrometry.
Kang L; Xu S; Pang Y; Kirchner T; Zhang YM; Edwards W; Camacho R; Norquay L; Weng N; Jian W
Bioanalysis; 2021 Mar; 13(6):465-479. PubMed ID: 33719526
[No Abstract] [Full Text] [Related]
47. Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry.
Fornelli L; Ayoub D; Aizikov K; Beck A; Tsybin YO
Anal Chem; 2014 Mar; 86(6):3005-12. PubMed ID: 24588056
[TBL] [Abstract][Full Text] [Related]
48. Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/tandem mass spectrometry: investigations of parameters that affect ruggedness.
Jemal M; Ouyang Z
Rapid Commun Mass Spectrom; 2003; 17(1):24-38. PubMed ID: 12478552
[TBL] [Abstract][Full Text] [Related]
49. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation.
Debaene F; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Anal Chem; 2013 Oct; 85(20):9785-92. PubMed ID: 24007193
[TBL] [Abstract][Full Text] [Related]
50. Development and validation of a (RP)UHPLC-UV-(HESI/Orbitrap)MS method for the identification and quantification of mixtures of intact therapeutical monoclonal antibodies using a monolithic column.
Pérez-Robles R; Cuadros-Rodríguez L; Salmerón-García A; Navas N
J Pharm Biomed Anal; 2018 Sep; 159():437-448. PubMed ID: 30071467
[TBL] [Abstract][Full Text] [Related]
51. High-Throughput Analysis of IgG Fc Glycopeptides by LC-MS.
Falck D; Jansen BC; de Haan N; Wuhrer M
Methods Mol Biol; 2017; 1503():31-47. PubMed ID: 27743357
[TBL] [Abstract][Full Text] [Related]
52. Investigation of Elemental Mass Spectrometry in Pharmacology for Peptide Quantitation at Femtomolar Levels.
Cordeau E; Arnaudguilhem C; Bouyssiere B; Hagège A; Martinez J; Subra G; Cantel S; Enjalbal C
PLoS One; 2016; 11(6):e0157943. PubMed ID: 27336163
[TBL] [Abstract][Full Text] [Related]
53. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
54. Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry.
Wang D; Wynne C; Gu F; Becker C; Zhao J; Mueller HM; Li H; Shameem M; Liu YH
Anal Chem; 2015 Jan; 87(2):914-21. PubMed ID: 25513708
[TBL] [Abstract][Full Text] [Related]
55. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.
Gahoual R; Biacchi M; Chicher J; Kuhn L; Hammann P; Beck A; Leize-Wagner E; François YN
MAbs; 2014; 6(6):1464-73. PubMed ID: 25484058
[TBL] [Abstract][Full Text] [Related]
56. Application of ultra-high-performance liquid chromatography coupled with LTQ-Orbitrap mass spectrometry for identification, confirmation and quantitation of illegal adulterated weight-loss drugs in plant dietary supplements.
Cheng Q; Shou L; Chen C; Shi S; Zhou M
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1064():92-99. PubMed ID: 28917128
[TBL] [Abstract][Full Text] [Related]
57. A Novel Online Four-Dimensional SEC×SEC-IM×MS Methodology for Characterization of Monoclonal Antibody Size Variants.
Ehkirch A; Goyon A; Hernandez-Alba O; Rouviere F; D'Atri V; Dreyfus C; Haeuw JF; Diemer H; Beck A; Heinisch S; Guillarme D; Cianferani S
Anal Chem; 2018 Dec; 90(23):13929-13937. PubMed ID: 30371058
[TBL] [Abstract][Full Text] [Related]
58. Subzero temperature chromatography and top-down mass spectrometry for protein higher-order structure characterization: method validation and application to therapeutic antibodies.
Pan J; Zhang S; Parker CE; Borchers CH
J Am Chem Soc; 2014 Sep; 136(37):13065-71. PubMed ID: 25152011
[TBL] [Abstract][Full Text] [Related]
59. The NISTmAb tryptic peptide spectral library for monoclonal antibody characterization.
Dong Q; Liang Y; Yan X; Markey SP; Mirokhin YA; Tchekhovskoi DV; Bukhari TH; Stein SE
MAbs; 2018 Apr; 10(3):354-369. PubMed ID: 29425077
[TBL] [Abstract][Full Text] [Related]
60. Broad screening of illicit ingredients in cosmetics using ultra-high-performance liquid chromatography-hybrid quadrupole-Orbitrap mass spectrometry with customized accurate-mass database and mass spectral library.
Meng X; Bai H; Guo T; Niu Z; Ma Q
J Chromatogr A; 2017 Dec; 1528():61-74. PubMed ID: 29122284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
